Amadix
PrivateLast Round
Series A
Nov 5, 2025
Total Funding Raised
$31.67M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Amadix is a biotechnology company that develops non-invasive diagnostic tests for early cancer detection in blood.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amadix Comparables
Compare Amadix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Epigenomics AG | 79% | |
| Freenome | 78% | |
| Singlera Genomics Inc. | 77% |
Amadix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 5, 2025 | ||||
| Grant | May 19, 2025 | ||||
| Debt | Feb 10, 2025 | ||||
| Grant | Jan 16, 2022 | ||||
| Crowdfunding | Dec 1, 2021 | ||||
Series A | Nov 28, 2019 |
Key People
Founding team and executive leadership
Amadix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| European Commission (Horizon Europe) | Grant |
| Inveready | Series A, M&A |
| Sodical Instituto Financiero de Castilla y León | Series A, M&A |
| European Commission | Grant |
| EIT Health | Grant |
| European Investment Bank Group | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 33% MoM, reaching 1.9K.
- Jul 26, 2026
Monthly visitors increased 51% MoM.
Amadix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Amadix's valuation, stock price, and market status.
Is Amadix a public or private company?
Amadix is a private company.
What is the current stock price of Amadix?
Amadix is a private company with no public stock price. No recent secondary market data is available.
How much is Amadix worth (valuation)?
Valuation information for Amadix is not publicly available.
Can I buy Amadix stock?
Amadix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Amadix's last funding round?
Amadix's most recent funding round was Debt on February 10, 2025.
Who are the main investors in Amadix?
Key investors in Amadix include European Commission, European Investment Bank Group, CRB Health Tech.
Will Amadix IPO soon?
No public IPO plans have been announced for Amadix.
How can I track Amadix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amadix's secondary market activity and sign up for updates.